Recent Successes Re-Vitalizing Interest in Continuous Blood Glucose Monitoring

(Nashua, NH) -  A new generation of blood glucose monitors is set to change the way patients manage their diabetes. The convergence of small-scale electronics and sophisticated biocompatible product designs is giving hope for a better future to millions of diabetes patients worldwide. Blood glucose monitors that are designed to be implanted and can continually measure glucose levels have the capability to improve glycemic control and patient wellbeing. By integrating the sensing element, electronics, and a power source in a single package, continuous blood glucose monitors are creating new options for caregivers and their diabetes patients. Sector participants are targeting a segment that will continue to expand due to the aging of the population in most developed countries, new criteria for the diagnosis of diabetes that emphasizes lower blood glucose thresholds and expansion of technologies into emerging market populations.

Signal processing improvements - including improved signal-to-noise ratios and interference filtering - will continue to be critical to the commercialization prospects of continuous blood glucose monitors. While the potential is substantial, for most participants the road to commercialization will contain numerous speed bumps and delays that will strain capitalization requirements and investor patience. Successful players will be those that realize the value of partnerships and strategic alliances.

These findings are contained in a new and comprehensive report - Continuous Glucose Monitors: the Current Generation and Beyond. The report examines key technology, design and economic factors impacting commercialization prospects for implantable monitors currently in development.

Source: Applied Data Research